OBJECTIVE Several studies have explored the impact of nonalcoholic fatty liver disease
(NAFLD) on risk of incident type 2 diabetes. However, the extent to which NAFLD may confer …

Abstract Background and Aim: The magnitude of the risk of incident type 2 diabetes (T2D)
and metabolic syndrome (MetS) among patients with nonalcoholic fatty liver disease …

Nonalcoholic fatty liver disease (NAFLD) is an alarming public health problem. The disease
is one of the main causes of chronic liver disease worldwide and is directly linked to the …

Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic steatosis (>
5% of hepatocytes by histology or> 5.6% by nuclear magnetic resonance techniques) in the …

Aims We aimed to conduct a systematic review and a meta-analysis to estimate NAFLD
prevalence and its change in Korea. Methods We searched the literature involving NAFLD …

Objective Follow-up studies have shown that non-alcoholic fatty liver disease (NAFLD) is
associated with an increased risk of incident diabetes, but currently, it is uncertain whether …

We investigated non‐alcoholic fatty liver disease (NAFLD) prevalence and its metabolic
associations in patients with type 1 diabetes (T1D), and in insulin‐naïve and insulin‐treated …

Background & Aims Cardiovascular disease remains the leading cause of death in patients
with nonalcoholic fatty liver disease (NAFLD). Studies examining the association of coronary …

Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of
metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by …

Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …